Literature DB >> 6540679

Activity of renal 25-hydroxyvitamin D3-1 alpha-hydroxylase in a case of X-linked hypophosphataemic rickets.

Y Seino, K Satomura, K Yamaoka, Y Tanaka, H Tanaka, T Yamamoto, M Ishida, H Yabuuchi.   

Abstract

In 1974, a 2-year-old boy was diagnosed as having X-linked hypophosphataemic rickets (XLH) because of severe rickets and hypophosphataemia. The vitamin D metabolite concentrations, blood and urine chemistry and renal 25-hydroxyvitamin D3 (25OHD3)-1 alpha-hydroxylase were measured in 1982 (about 2 weeks after withdrawal of medication). 1 alpha-hydroxylase was 392 pg/mg tissue/20 min in the patient, which was high compared with aged-matched controls (69.7 +/- 28.5 pg/mg tissue/20 min, mean +/- SD, n = 7). Our present studies showed that the 1 alpha-hydroxylase activity in the patient with XLH was elevated. Therefore, the normal or low 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3) concentrations in XLH patients could be due to accelerated catabolism of 1,25-(OH)2D3 or abnormally regulated 25OHD3-1 alpha-hydroxylase in response to hypophosphataemia, although significantly elevated above that in normal controls.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6540679     DOI: 10.1007/bf00442454

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  14 in total

1.  Biochemical characterization of 1,25(OH)2D3 receptors in chick embryonal duodenal cytosol.

Authors:  Y Seino; K Yamaoka; M Ishida; H Yabuuchi; M Ichikawa; H Ishige; H Yoshino; L V Avioli
Journal:  Calcif Tissue Int       Date:  1982-05       Impact factor: 4.333

2.  Treatment of hypophosphataemic vitamin D-resistant rickets with massive doses of 1 alpha-hydroxy-vitamin D3 during childhood.

Authors:  Y Seino; T Shimotsuji; T Ishii; M Ishida; C Ikehara; K Yamaoka; H Yabuuchi; S Dokoh
Journal:  Arch Dis Child       Date:  1980-01       Impact factor: 3.791

3.  Measurement of mammalian 25-hydroxyvitamin D3 24R-and 1 alpha-hydroxylase.

Authors:  Y Tanaka; H F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

4.  Serum 1,25-dihydroxyvitamin D levels in subjects with X-linked hypophosphatemic rickets and osteomalacia.

Authors:  K W Lyles; A G Clark; M K Drezner
Journal:  Calcif Tissue Int       Date:  1982-03       Impact factor: 4.333

5.  I alpha, 25-Dihydroxyvitamin D3 receptor in the X-linked hypophosphatemic mouse.

Authors:  Y Seino; R I Sierra; M Ichikawa; L V Avioli
Journal:  Endocrinology       Date:  1982-07       Impact factor: 4.736

6.  A microassay for mammalian renal 25-hydroxyvitamin D3-1-hydroxylase applicable to man.

Authors:  Y Tanaka; H F DeLuca; K Satomura; K Yamaoka; Y Seino
Journal:  J Lab Clin Med       Date:  1983-12

7.  Abnormal 24-hydroxylation of 25-hydroxyvitamin D in the X-linked hypophosphatemic mouse.

Authors:  J Cunningham; H Gomes; Y Seino; L R Chase
Journal:  Endocrinology       Date:  1983-02       Impact factor: 4.736

8.  Vitamin D metabolism in hypophosphatemic vitamin D-resistant rickets.

Authors:  Y Seino; T Shimotsuji; M Ishida; T Ishii; K Yamaoka; H Yabuuchi
Journal:  Contrib Nephrol       Date:  1980       Impact factor: 1.580

9.  Serum calcium regulating hormones in the perinatal period.

Authors:  Y Seino; M Ishida; K Yamaoka; T Ishii; T Hiejima; C Ikehara; Y Tanaka; S Matsuda; T Shimotsuji; H Yabuuchi; S Morimoto; T Onishi
Journal:  Calcif Tissue Int       Date:  1982-03       Impact factor: 4.333

10.  Abnormal vitamin D metabolism in the X-linked hypophosphatemic mouse.

Authors:  R A Meyer; R W Gray; M H Meyer
Journal:  Endocrinology       Date:  1980-11       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.